| 注册
首页|期刊导航|中国社区医师|西妥昔单抗联合化疗治疗消化系统肿瘤的临床研究

西妥昔单抗联合化疗治疗消化系统肿瘤的临床研究

李霞

中国社区医师Issue(33):46-46,48,2.
中国社区医师Issue(33):46-46,48,2.DOI:10.3969/j.issn.1007-614x.2014.33.27

西妥昔单抗联合化疗治疗消化系统肿瘤的临床研究

Clinical study of cetuximab combined with chemotherapy in the treatment of tumor of digestive system

李霞1

作者信息

  • 1. 277100山东省枣庄矿业集团枣庄医院肿瘤内科
  • 折叠

摘要

Abstract

Objective:To explore the clinical effect of cetuximab combined with chemotherapy in the treatment of tumor of digestive system.Methods:80 patients with digestive system tumor were selected from March 2012 to March 2013.They were randomly divided into the control group and the observation group with 40 cases in each group.The control group were treated with general treatment.The observation group were treated with cetuximab combined with chemotherapy.We compared the treatment effect of the two groups.Results:In the observation group,the total efficiency was 90% .In the control group,the total efficiency was 70%.The treatment effect of the observation group was obviously better than the control group,and the difference was statistically significant(P<0.05).Conclusion:The clinical effect of cetuximab combined with chemotherapy in the treatment of tumor of digestive system is significant.

关键词

西妥昔单抗联合化疗/消化系统肿瘤/临床研究

Key words

Cetuximab combined with chemotherapy/Digestive system tumor/The clinical study

引用本文复制引用

李霞..西妥昔单抗联合化疗治疗消化系统肿瘤的临床研究[J].中国社区医师,2014,(33):46-46,48,2.

中国社区医师

1007-614X

访问量0
|
下载量0
段落导航相关论文